Interstitial lung disease: FDA reporting patterns
47,671 FDA FAERS reports mention Interstitial lung disease. 47,227 reports have a serious outcome flag.
Medicines named as suspect
- Methotrexate: 3,704 reports
- Rituximab: 2,948 reports
- Pembrolizumab: 2,394 reports
- Cyclophosphamide: 2,152 reports
- Prednisone: 2,071 reports
- Amiodarone: 1,909 reports
- Doxorubicin: 1,675 reports
- Etanercept: 1,659 reports
- Nivolumab: 1,655 reports
- Paclitaxel: 1,620 reports
- Adalimumab: 1,543 reports
- Tocilizumab: 1,405 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.